JP's Classification of Drugs
3 ratings
)Overview
Global Drug Reference.
JP'S CLASSIFICATION OF DRUGS V 5.0 โ GLOBAL PHARMACOLOGICAL REFERENCE A structured, offline drug classification reference covering 1,800+ drugs across 24 pharmacological chapters. Built for pharmacovigilance professionals, medical officers, pharmacists, clinicians, and students who need rapid, reliable access to drug classification data without opening a textbook or waiting for a website to load. โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ WHAT IT COVERS โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ 24 chapters organised by pharmacological mechanism, not by trade name or therapeutic area. It also provides selected drug-approval and regulatory reference information from major international regulatory authorities. โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ REGULATORY COVERAGE โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ Drugs approved by major global regulatory authorities are included: US FDA, EMA (European Medicines Agency), Japan PMDA, China NMPA, MFDS. โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ WHAT YOU SEE FOR EACH DRUG โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ โข International Nonproprietary Name (INN) โข General synonyms and common brand names โข Dosing information (where confirmed from regulatory sources) โข Classification path (chapter โ subclass โ subgroup) โข All terms are searchable โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ HOW TO USE IT โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ SEARCH โ Type any drug name, INN, synonym, brand name, or drug class into the search box. Results appear instantly. Click any result to navigate directly to that drug's classification page. BROWSE โ Use the chapter dropdown to select a pharmacological system. An overview of all subclasses appears with clickable chips. Select any subclass from the second dropdown โ or click directly on a chip โ to see the full classification tree with all drugs listed. EXPAND โ Click any drug entry to expand and see its dose, synonyms, and brand names. Click the subgroup header bar to collapse or expand the whole subgroup. โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ WHAT MAKES IT DIFFERENT โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ This tool follows the pharmacological classification system โ organised by mechanism of action, receptor target, and chemical class. โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ PRIVACY โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ No external servers. No login required. All drug data is bundled with the extension and read locally. The extension makes no network requests. It cannot read the pages you visit and requests no host permissions. โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ IMPORTANT NOTICE โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ This extension is a pharmacological reference and educational tool only. It is not a clinical decision support system and does not constitute medical or regulatory advice. Dosing information is indicative and sourced from published regulatory documents; always verify against current prescribing information before clinical use. Drug approvals and classifications change โ always confirm against the current regulatory authority guidance for your jurisdiction. โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ DEVELOPED BY โโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโโ Jayprakash Lokhande https://www.linkedin.com/in/jayaprakash0011/ Email - logixmagix@proton.me
5 out of 53 ratings
Details
- Version5.0
- UpdatedSeptember 19, 2026
- Size129KiB
- LanguagesEnglish (United Kingdom)
- Developer
Email
logixmagix@proton.me - Non-traderThis developer has not identified itself as a trader. For consumers in the European Union, please note that consumer rights do not apply to contracts between you and this developer.
Privacy
This developer declares that your data is
- Not being sold to third parties, outside of the approved use cases
- Not being used or transferred for purposes that are unrelated to the item's core functionality
- Not being used or transferred to determine creditworthiness or for lending purposes